Supplement Bill Increasing FDA Access To Safety Data Planned By Waxman
This article was originally published in The Tan Sheet
Executive Summary
Reps. Henry Waxman (D-Calif.) and Susan Davis (D-Calif.) are working on legislation "that will give FDA greater access to information to understand if a [dietary supplement] product does pose a health risk and will let FDA protect consumers from unsafe products," Waxman said at a July 23 hearing of the House Energy & Commerce/Oversight & Investigations Subcommittee
You may also be interested in...
Mandatory AER sponsor in House?
Rep. Greg Walden (R-Ore.) is expected to assume the chairmanship of the Energy & Commerce/Oversight & Investigations Subcommittee with Rep. James Greenwood's (R-Penn.) decision to become president of the Biotechnology Industry Organization. Greenwood will finish his term before joining BIO Jan. 5, but has resigned his post as subcommittee chair. Walden's leadership could provide a forum in the House for debating mandatory adverse event reporting for supplements, an issue soon to be tackled in the higher chamber by Sens. Richard Durbin (D-Ill.) and Orrin Hatch (R-Utah) (1"The Tan Sheet" June 28, 2004, p. 3). Walden has expressed support for mandatory reporting in the past (2"The Tan Sheet" July 28, 2003, p. 3). The Oregonian Republican also spearheaded efforts to ban ephedra, including sponsorship of a related bill in March 2003 and a subpoena of Metabolife execs...
Mandatory AER sponsor in House?
Rep. Greg Walden (R-Ore.) is expected to assume the chairmanship of the Energy & Commerce/Oversight & Investigations Subcommittee with Rep. James Greenwood's (R-Penn.) decision to become president of the Biotechnology Industry Organization. Greenwood will finish his term before joining BIO Jan. 5, but has resigned his post as subcommittee chair. Walden's leadership could provide a forum in the House for debating mandatory adverse event reporting for supplements, an issue soon to be tackled in the higher chamber by Sens. Richard Durbin (D-Ill.) and Orrin Hatch (R-Utah) (1"The Tan Sheet" June 28, 2004, p. 3). Walden has expressed support for mandatory reporting in the past (2"The Tan Sheet" July 28, 2003, p. 3). The Oregonian Republican also spearheaded efforts to ban ephedra, including sponsorship of a related bill in March 2003 and a subpoena of Metabolife execs...
Mandatory AER sponsor in House?
Rep. Greg Walden (R-Ore.) is expected to assume the chairmanship of the Energy & Commerce/Oversight & Investigations Subcommittee with Rep. James Greenwood's (R-Penn.) decision to become president of the Biotechnology Industry Organization. Greenwood will finish his term before joining BIO Jan. 5, but has resigned his post as subcommittee chair. Walden's leadership could provide a forum in the House for debating mandatory adverse event reporting for supplements, an issue soon to be tackled in the higher chamber by Sens. Richard Durbin (D-Ill.) and Orrin Hatch (R-Utah) (1"The Tan Sheet" June 28, 2004, p. 3). Walden has expressed support for mandatory reporting in the past (2"The Tan Sheet" July 28, 2003, p. 3). The Oregonian Republican also spearheaded efforts to ban ephedra, including sponsorship of a related bill in March 2003 and a subpoena of Metabolife execs...